[Federal Register Volume 83, Number 70 (Wednesday, April 11, 2018)]
[Notices]
[Page 15633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07444]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: 
    The companies listed below applied to be registered as importers of 
various basic classes of controlled substances. Information on 
previously published notices is listed in the table below. No comments 
or objections were submitted and no requests for hearing were submitted 
for these notices.

----------------------------------------------------------------------------------------------------------------
                Company                            FR docket                            Published
----------------------------------------------------------------------------------------------------------------
Sharp (Bethlehem), LLC................  83 FR 539.....................  January 4, 2018.
Catalent Pharma Solutions, LLC........  83 FR 2215....................  January 16, 2018.
Janssen Pharmaceuticals, Inc..........  83 FR 2214....................  January 16, 2018.
Mylan Pharmaceuticals, Inc............  83 FR 5809....................  February 9, 2018.
Meridian Medical Technologies, Inc....  83 FR 5810....................  February 9, 2018.
Noramco, Inc..........................  83 FR 5810....................  February 9, 2018.
Johnson Matthey, Inc..................  83 FR 5811....................  February 9, 2018.
Mylan Technologies, Inc...............  83 FR 5811....................  February 9, 2018.
Mylan Pharmaceuticals, Inc............  83 FR 8107....................  February 23, 2018.
----------------------------------------------------------------------------------------------------------------

    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of the listed registrants to import the applicable basic 
classes of schedule I or II controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each company's maintenance of effective 
controls against diversion by inspecting and testing each company's 
physical security systems, verifying each company's compliance with 
state and local laws, and reviewing each company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed companies.

    Dated: April 4, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-07444 Filed 4-10-18; 8:45 am]
 BILLING CODE 4410-09-P